276 CIRCULATING FORMS OF PLASMA TRANSTHYRETIN IN PATIENTS WITH WILD-TYPE TRANSTHYRETIN AMYLOIDOSIS AND EFFECTS OF TREATMENT WITH TAFAMIDIS
نویسندگان
چکیده
Abstract Introduction Transthyretin (TTR) is a homotetrameric 55-KDa plasma protein that transports thyroxin and retinol complexed to retinol-binding (RBP). TTR misfolding aggregation can lead the extracellular deposition of amyloid (ATTR) representing one most frequent forms amyloidosis in elderly. Aim this study develop native electrophoretic method characterize circulating samples ATTR patients before during treatment with tafamidis, stabilizer. Methods Plasma from (n=6), collected (T0) tafamidis treatment, healthy controls (n=6) were obtained Fondazione Toscana G. Monasterio (Pisa, Italy). separated on 4–20% Tris-Gly polyacrylamide gel. Western blot analysis was performed anti-TTR (DAKO) or anti-RBP (Siemens Healthineer) antibodies. Proteins detected by Clarity ECL substrate (BioRad). Results Circulating qualitatively similar between ATTRwt at T0 controls. In both groups, represented were: dimers trimers (∼37-50 kDa), tetramers RBP 1:1 ratio (∼80 kDa,) 1:2 (∼100 high molecular weight (MW) aggregates (>150 kDa). Neither monomers nor visible. detectable association some higher MW fractions (∼150 kDa, >250 Following all displayed progressive increase intensity band corresponding TTR-RBP complexes, agreement drug stabilizing action tetramers. Interestingly trimers, T0, progressively lost treatment. Conclusions The allowed us detect several fractions. Data suggest pattern control: tetramer exists only equilibrium low forms. Furthermore, appreciate effect RBP. expand our knowledge mechanisms triggering its destabilization even when not mutated.
منابع مشابه
Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
This phase II, open-label, single-treatment arm study evaluated the pharmacodynamics, efficacy, and safety of tafamidis in patients with non-Val30Met transthyretin (TTR) amyloidosis. Twenty-one patients with eight different non-Val30Met mutations received 20 mg QD of tafamidis meglumine for 12 months. The primary outcome, TTR stabilization at Week 6, was achieved in 18 (94.7%) of 19 patients wi...
متن کاملWild-type transthyretin amyloidosis in female patients
Results Comparison of clinical findings between males and females affected by wt-ATTR amyloidosis are shown in table 1. Female patients with wt-ATTR did not differ from male patients regarding demographic or clinical parameters except for modified body mass index (1140±184 vs. 1029±154, p<0.05), glomerular filtration rate (66±23 vs. 85±31 ml/min*m*1.73; p<0.05), NYHA class (2.4±0.7 vs. 2.9±0.3;...
متن کاملGreen tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study
BACKGROUND Causative treatment of patients with wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is lacking. Recent reports indicate the potential use of epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea, to inhibit amyloid fibril formation. We sought to investigate changes of cardiac function and morphology in patients with wtATTR-CM after consumption of gree...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal Supplements
سال: 2022
ISSN: ['1520-765X', '1554-2815']
DOI: https://doi.org/10.1093/eurheartjsupp/suac121.578